[Modulation of transcranial electroanalgesia by effecting the serotoninergic system of the brain].
Savchenko
A B
AB
Lebedev
V P
VP
Nozdrachev
A D
AD
D006916:5-Hydroxytryptophan / Q000494:pharmacology / Q000627:therapeutic use; D000493:Allopurinol / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D009526:Nialamide / Q000494:pharmacology / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000502:physiology*; D004561:Transcutaneous Electric Nerve Stimulation; D014364:Tryptophan / Q000494:pharmacology / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D012701:Serotonin; D000493:Allopurinol; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D009526:Nialamide
Moduliatsiia transkranial'noĭ élektroanal'gezii vozdeĭstviem na serotoninergicheskuiu sistemu mozga.